| Year |
Citation |
Score |
| 2007 |
Suskin NG, Heigenhauser G, Afzal R, Finegood D, Gerstein HC, McKelvie RS. The effects of exercise training on insulin resistance in patients with coronary artery disease. European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups On Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology. 14: 803-8. PMID 18043303 DOI: 10.1097/Hjr.0B013E3282Eea540 |
0.307 |
|
| 2003 |
Hamilton J, Cummings E, Zdravkovic V, Finegood D, Daneman D. Metformin as an adjunct therapy in adolescents with type 1 diabetes and insulin resistance: a randomized controlled trial. Diabetes Care. 26: 138-43. PMID 12502670 DOI: 10.2337/Diacare.26.1.138 |
0.388 |
|
| 1999 |
Legro RS, Finegood D, Dunaif A. A Fasting Glucose To Insulin Ratio Is A Useful Measure Of Insulin Sensitivity In Women With Polycystic Ovary Syndrome Obstetrical & Gynecological Survey. 54: 35-36. DOI: 10.1097/00006254-199901000-00019 |
0.395 |
|
| 1998 |
Legro RS, Finegood D, Dunaif A. A Fasting Glucose to Insulin Ratio Is a Useful Measure of Insulin Sensitivity in Women with Polycystic Ovary Syndrome The Journal of Clinical Endocrinology and Metabolism. 83: 2694-2698. PMID 9709933 DOI: 10.1210/Jcem.83.8.5054 |
0.397 |
|
| 1997 |
Dunaif A, Scott D, Finegood D, Quintana B, Whitcomb R. The Insulin-Sensitizing Agent Troglitazone Improves Metabolic and Reproductive Abnormalities in the Polycystic Ovary Syndrome Obstetrical & Gynecological Survey. 52: 110-111. DOI: 10.1097/00006254-199702000-00016 |
0.344 |
|
| 1996 |
Dunaif A, Scott D, Finegood D, Quintana B, Whitcomb R. The Insulin-Sensitizing Agent Troglitazone Improves Metabolic and Reproductive Abnormalities in the Polycystic Ovary Syndrome* The Journal of Clinical Endocrinology and Metabolism. 81: 3299-3306. PMID 8784087 DOI: 10.1210/Jcem.81.9.8784087 |
0.396 |
|
| 1996 |
Kneteman NM, Lakey JRT, Wagner T, Finegood D. The metabolic impact of rapamycin (sirolimus) in chronic canine islet graft recipients Transplantation. 61: 1206-1210. PMID 8610419 DOI: 10.1097/00007890-199604270-00015 |
0.395 |
|
| 1992 |
Hramiak I, Dupre J, Finegood D. Determinants of prolonged (> 1 year) Non-Insulin-Receiving (NIR) remission of IDDM during cyclosporine A (CsA treatment) Journal of Autoimmunity. 5. DOI: 10.1016/0896-8411(92)90113-5 |
0.361 |
|
| Show low-probability matches. |